This real-world study suggests that improved clinical outcomes are possible in the difficult-to-treat elderly patients with type 2 diabetes group without affecting healthcare costs, by initiating insulin therapy with a pen device.
Steve Zhou, PhD
Advertisement
Articles by Steve Zhou, PhD
Advertisement
Latest Updated Articles
- Impact of Insulin Delivery Systems in Elderly Patients With Type 2 Diabetes
Published: October 23rd 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
2
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
3
Medetomidine: The Demon in the Illicit Fentanyl Supply
4
FDA Updates Boxed Warning for Cilta-Cel Following Reports of Immune Effector Cell–Associated Enterocolitis
5
